Evaluation of the Bioavailability of Pramlintide
NCT00042471
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
75
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes Mellitus, Type 1
Diabetes Mellitus, Type 2
Interventions
DRUG:
Pramlintide acetate
Sponsor
AstraZeneca